Professor Arri Coomarasamy

Professor Arri Coomarasamy is the Director of the Tommy’s National Centre for Miscarriage Research, based at the University of Birmingham, University of Warwick and Imperial College London. He is also the co-director of the WHO Collaborating Centre for Global Women’s Health at the University of Birmingham.

Arri’s research portfolio includes numerous national and international multicentre randomised controlled trials, including the PROMISE Trial (NEJM, 2015), the CHAMPION Trial (NEJM, 2018), the TABLET Trial (NEJM, 2019), the AIMS Trial (NEJM, 2019), the PRISM Trial (NEJM, 2019), the MifeMiso Trial (Lancet, 2020), and the E-MOTIVE Trial (NEJM, 2023). Professor Arri Coomarasamy has published over 300 medical articles in high impact journals such as the New England Journal of Medicine, the Lancet, the British Medical Journal and the Cochrane Database of Systematic Reviews. Professor Coomarasamy takes particular pride in mentoring junior doctors and researchers, and several of his trainees have become outstanding clinicians and researchers. He is the founding trustee of Ammalife, a UK-registered charity with a global mission of reducing maternal deaths in low-income countries.

Find out more about Professor Arri Coomarasamy